These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12592417)

  • 1. Surveillance study of Sinupret in comparison with data of the Mainz birth registry.
    Ismail C; Wiesel A; März RW; Queisser-Luft A
    Arch Gynecol Obstet; 2003 Feb; 267(4):196-201. PubMed ID: 12592417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the Hungarian Birth Defects Registry for surveillance, research and intervention.
    Siffel C; Czeizel AE
    Cent Eur J Public Health; 1997 Jun; 5(2):79-81. PubMed ID: 9208163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based case-control study of oral griseofulvin treatment during pregnancy.
    Czeizel AE; Métneki J; Kazy Z; Puho E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):827-31. PubMed ID: 15315593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
    Colvin J; Bower C; Dickinson JE; Sokol J
    Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of abnormalities in Magdeburg according to the Mainz model].
    Rösch C; Steinbicker V; Gosch G; Weise W; Knittel B; Canzler E
    Z Geburtshilfe Neonatol; 1998 Sep; 202(5):197-202. PubMed ID: 9857445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research.
    Lisi A; Botto LD; Robert-Gnansia E; Castilla EE; Bakker MK; Bianca S; Cocchi G; de Vigan C; Dutra Mda G; Horacek J; Merlob P; Pierini A; Scarano G; Sipek A; Yamanaka M; Mastroiacovo P
    Reprod Toxicol; 2010 Jul; 29(4):433-42. PubMed ID: 20347959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating prevalence of fetal alcohol syndrome (FAS): effectiveness of a passive birth defects registry system.
    Fox DJ; Druschel CM
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):604-8. PubMed ID: 14703781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring for congenital malformations.
    Holtzman NA; Khoury MJ
    Annu Rev Public Health; 1986; 7():237-66. PubMed ID: 3521645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.
    Wikner BN; Stiller CO; Bergman U; Asker C; Källén B
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1203-10. PubMed ID: 17894421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senna treatment in pregnant women and congenital abnormalities in their offspring--a population-based case-control study.
    Acs N; Bánhidy F; Puhó EH; Czeizel AE
    Reprod Toxicol; 2009 Jul; 28(1):100-4. PubMed ID: 19491001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based case-control study of mebendazole in pregnant women for birth outcomes.
    Acs N; Bánhidy F; Puhó E; Czeizel AE
    Congenit Anom (Kyoto); 2005 Sep; 45(3):85-8. PubMed ID: 16131365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations.
    Drinkard CR; Shatin D; Clouse J
    Pharmacoepidemiol Drug Saf; 2000 Dec; 9(7):549-56. PubMed ID: 11338912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs.
    Czeizel AE; Gidai J; Petik D; Timmermann G; Puhó EH
    Toxicol Ind Health; 2008; 24(1-2):11-28. PubMed ID: 18818178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
    Viinikainen K; Heinonen S; Eriksson K; Kälviäinen R
    Epilepsia; 2006 Jan; 47(1):186-92. PubMed ID: 16417548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Gaughan WJ; Philips LZ; McGrory CH; Coscia LA;
    Clin Transpl; 2002; ():121-30. PubMed ID: 12971441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):41-51. PubMed ID: 18818180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
    Schaefer C
    Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based case-control teratologic study of furazidine, a nitrofuran-derivative treatment during pregnancy.
    Czeizel AE; Rockenbauer M; Sørensen HT; Olsen J
    Clin Nephrol; 2000 Apr; 53(4):257-63. PubMed ID: 10809412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.